NCT00064025 · Interventional trial
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
Overall registry status Completed
Phase 2
Conditions Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Recurrent Uterine Corpus Carcinoma, Stage I Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer
Delaware Valley sites
- Gynecologic Oncology Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory